The serotonergic system in ageing and Alzheimer's disease.
about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsSerotonin, neural markers, and memoryNeuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease PathogenesisSerotonergic chemosensory neurons modify the C. elegans immune response by regulating G-protein signaling in epithelial cellsProof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer's Dementia.SK3 Channel Overexpression in Mice Causes Hippocampal Shrinkage Associated with Cognitive Impairments.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic RatsEvidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease.Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques.Metabolomics Approach Reveals Integrated Metabolic Network Associated with Serotonin Deficiency.Principles and management of neuropsychiatric symptoms in Alzheimer's dementiaPrecortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal PathologyGenomic and epigenomic insights into nutrition and brain disordersRedundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo.Up-regulation of serotonin receptor 2B mRNA and protein in the peri-infarcted area of aged rats and stroke patients.The serotonergic system and cognitive functionBehavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.Comparison of the Antidepressant-Like Effects of Estradiol and That of Selective Serotonin Reuptake Inhibitors in Middle-Aged Ovariectomized Rats.Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.Non human primate models for Alzheimer's disease-related research and drug discovery.Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis.Integrins in synapse regulation.Is dependent personality disorder associated with mild cognitive impairment and dementia in Central Africa? A result from the EPIDEMCA programme.Escitalopram Ameliorates Tau Hyperphosphorylation and Spatial Memory Deficits Induced by Protein Kinase A Activation in Sprague Dawley Rats.Association between the serotonin transporter gene polymorphism and verbal learning in older adults is moderated by gender.Editorial: Serotonin and Memory.A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative diseaseAcute treatment with bis selenide, an organic compound containing the trace element selenium, prevents memory deficits induced by reserpine in rats.Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry.
P2860
Q26749755-590D7033-D0FD-4229-B57F-1A7775C04351Q26751302-10292100-44AA-40FA-B73F-1D41EBE2062BQ26800204-52E7E5DF-B7E4-4515-8C73-4D6B16680A28Q26827219-3BFB24FE-EC7B-458D-BE94-2B9E77651C97Q27027221-E1DD6DF7-01FE-4064-95C5-6A75268DA4F5Q27331883-8B8E307A-0926-40EE-9F1E-2BFF305BE42CQ30426397-924BFAB0-FE47-471A-8B18-EDE3604AE398Q30838734-DD3C6181-CE72-4228-B2B4-A901B5B5BC5BQ34424865-30C97F9C-3697-415C-A917-19E8F384209CQ34735142-CE00B007-E40E-402A-B8C4-06AEDC45AD92Q34804269-1F6A3586-87CC-4C6E-A902-961C61E2D778Q34979750-66F072CA-2D15-425B-921B-7894F7C40981Q35014204-8ADF5E31-21DB-4433-990B-6C84A12FF4E4Q35053378-24907D5D-F547-40E9-B0F6-E5EE279DC617Q35502548-EC02FF45-C53E-46DA-A01F-C494FB723061Q35544686-04BEBAD5-C02F-4CD5-80CA-3BAFB8C487EFQ35829940-B21CCBE5-E082-4B2D-A928-6C57E707629EQ36063264-2199C72A-4942-4482-9A37-A6B5A7E4CB10Q36484091-416D1AE3-37FB-43EB-A05E-C387D5183FAFQ36994014-AC1F896F-10F8-41A5-AE03-66B485438CD6Q37018138-1618A3AB-EDAA-4FFB-83A6-D00452E25F52Q37109496-889E0EB2-E345-410B-AD41-94847149628FQ37245282-B8D09CE7-1D2A-46A0-935D-EA766A247ADCQ37395530-8B66264B-0F7E-4AC6-AF49-E368D7E12DD2Q37521370-F304FAE1-4B7E-431E-B62B-27F5044343AEQ37590630-7A518FA2-5367-47BA-B04B-90B9ACB1A462Q38178842-5690F07D-CD03-4D04-ADBF-2B89E301E0F2Q38737187-7E12644C-A467-4739-92CA-53F706596368Q38783343-19DD0389-443A-47D4-A66E-1B4D4BD1359DQ38881147-9BB3726B-613B-4A61-A6DA-E4E5844EC479Q38962789-CF383AAB-81C1-4653-8CC6-465365524D87Q38985928-4ABF1E95-5367-43BF-8FF2-65A6B64D0770Q38998162-F85BDF53-EAF3-43AE-A542-267ACB971DF5Q39356472-745BD51D-360E-4645-9C9D-3A15AB4F39F8Q40506203-4A9F7B3E-7B88-42C8-9F7C-EE63C38815EDQ41194037-83AFEB3A-E907-413E-A6AE-0659A989412EQ41789368-2F1D44BF-0C4E-4405-8A4C-4696CF6F575BQ42363726-C4D626B0-03E8-499F-A057-B5F2E883ED5CQ42675514-1A5E20B3-3341-4387-A996-D516FF749828Q46694997-13AEE5E9-C7EE-40EE-BA8A-2D19DF063E52
P2860
The serotonergic system in ageing and Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The serotonergic system in ageing and Alzheimer's disease.
@en
type
label
The serotonergic system in ageing and Alzheimer's disease.
@en
prefLabel
The serotonergic system in ageing and Alzheimer's disease.
@en
P1476
The serotonergic system in ageing and Alzheimer's disease.
@en
P2093
Harun N Noristani
José Julio Rodríguez
P356
10.1016/J.PNEUROBIO.2012.06.010
P577
2012-07-02T00:00:00Z